Further, studies showed that miR-17 inhibits S1P induced migration of thyroid follicular carcinoma cells by targeting PTK6 and inhibiting ERK1/2 signaling (Fig. 6I). Here, MAPK3 is linked to thyroid gland follicular carcinoma.